[1] |
曹翠萍,王菡,任广运,等.老年黄斑变性的患病情况[J].中国老年学杂志,2013,33(8):1956-1957.
|
[2] |
范瑞,潘星月,杨红梅,等.老年黄斑变性患者影响因素对照调查分析[J].中国实用眼科杂志,2009,27(9):1048-1050.
|
[3] |
汪明芳,马乐,黄旸木,等.早期老年黄斑变性患者血清叶黄素水平相关因素分析[J].中华老年医学杂志,2013,32(10):1083-1086.
|
[4] |
张秀芝.激光联合卵磷脂络合碘治疗视网膜黄斑分支静脉阻塞[J].重庆医学,2012,41(31):3265-3266.
|
[5] |
张承芬.眼底病学[M].2版.北京:人民卫生出版社,2010:273.
|
[6] |
廉丽华,朱淑婷.Avastin治疗湿性年龄相关性黄斑变性的疗效观察[J].实用中西医结合临床,2014,14(3):58-59.
|
[7] |
Park JH,Woo SJ,Ha YJ,et al.Macular capillary blood flow in patients with diffuse diabetic macular edema without vitreomacular traction[J].Ophthalmic Res,2009,42(2):73-80.
|
[8] |
王秀兰.武开寿冲药联合曲安奈德球旁注射治疗黄斑囊样水肿疗效观察[J].中国中医眼科杂志,2012,22(3):175-176.
|
[9] |
Salem W,Fraser-Bell S,Gillies M.Clinical development of new treatments for diabeticmacular oedema[J].Clin Exp Optom,2012,95(3):297-305.
|
[10] |
王安之,吕涛,吴双有.单波长绿激光治疗糖尿病视网膜病变40例疗效及安全性评价[J].陕西医学杂志,2012,41(9):1163-1164.
|
[11] |
杨杰,彭振宇,黄慧,等.激光联合曲安奈德治疗糖尿病黄斑水肿的疗效[J].国际眼科杂志,2013,13(5):960-962.
|
[12] |
张坚,马勇,谢安明.曲安奈德玻璃体内注射治疗黄斑水肿对眼压的影响观察[J].陕西医学杂志,2007,36(9):1172-1174.
|
[13] |
曾铃,李晟,廖品正,等.糖尿病性黄斑水肿与激光治疗[J].中华现代眼耳鼻喉科杂志,2007,4(2):128-133.
|
[14] |
Noma H,Funatsu H,Mimura T,et al.Role of soluble vascular endothelial growth factor receptor-2 in macular oedema with central retinal vein occlusion[J].Br JDphthalmol,2011,95(6):788-792.
|
[15] |
Noma H,Funatsu H,Mimura T,et al.Vascular endothelial growth factor receptor-2 in macular oedema with retinal vein occlusion[J].Ophthalmic Res,2012,48(1):56-58.
|
[16] |
Mete A,SaygiliO,Gungor K,etal.Does ranibizumab(Lueenfis)change retrobulbar blood flow in patients with neovascular age-related macular degeneration?[J].Ophthalmic Res,2012,47(3):141-145.
|
[17] |
赵全良,张春香.玻璃体腔注射Bevacizumab联合视网膜光凝治疗糖尿病性黄斑水肿[J].国际眼科杂志,2013,13(8):1651-1653.
|
[18] |
严桢桢,朱蓉嵘,陈辉.眼内注射雷珠单克隆抗体对年龄相关性黄斑变性视网膜血管及视力恢复的影响[J].中国临床医学,2015,22(1):105-107.
|
[19] |
吴木振.雷珠单抗治疗视网膜静脉阻塞继发黄斑水肿的效果及安全性的系统评价[J].中国现代医生,2016,54(8):72-74.
|